Anna Van Acker News Today

The Pennsylvania Bankers Association (PA Bankers) announced and honored the winners of its annual Women in Banking Recognition of Excellence Awards during a conference at Hershey Lodge & Convention Center

Many CEOs of multinational companies have confirmed their attendance at the 6th China International Import Expo, the organizer announced during a promotional event for the annual expo's medical equipment and healthcare products zone on March 31.

Merck Canada and MaRS Announce Winners of the Lung Cancer Innovation Challenge News provided by Share this article Share this article Challenge participants presented solutions aimed at improving patient outcomes and reducing time between diagnosis and treatment for lung cancer patients Challenge winners include  the Kingston Health Sciences Centre and the Princess Margaret Cancer Centre, with solutions to help improve timely access to specialized care in rural South Eastern Ontario and accele...

DUA U of T and Merck Canada partner to advance and share vaccine knowledge and research A $3-million contribution from Merck Canada Inc. to the Dalla Lana School of Public Health’s Centre for Vaccine Preventable Diseases reinforces U of T’s role as a leader in the advancement of immunization and vaccine science (photo by Johnny Guatto) As Canada marks National Immunization Awareness Week, a new investment from Merck Canada to the University of Toronto’s Centre for Vaccine Preventabl...

 E-Mail As Canada marks National Immunization Awareness Week, a new investment from Merck Canada to the University of Torontos Centre for Vaccine Preventable Diseases (CVPD) at the Dalla Lana School of Public Health (DLSPH) will support research, education, and knowledge translation around vaccine science and help communicate the importance of immunization as a cornerstone of public health. Merck Canadas $3-million investment will help the Centres diverse mix of public health researchers to b...

KEYTRUDA ® is an anti-PD-1 therapy that works by helping increase the ability of the bodys immune system to help detect and fight tumour cells. 1 An estimated 26,900 Canadians were diagnosed with colorectal cancer in 2020, with an average of 73 Canadians diagnosed daily. 2 KIRKLAND, QC, March 8, 2021 /CNW/ - Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that Health Canada has approved KEYTRUDA ® (pembrolizumab), Mercks anti-PD-1 therapy, for the first...

Approval Based on Significant Progression Free Survival Findings from Phase 3 KEYNOTE-177 Trial KEYTRUDA ® is an anti-PD-1 therapy that works by helping increase the ability of the body’s immune system to help detect and fight tumour cells. 1 An estimated 26,900 Canadians were diagnosed with colorectal cancer in 2020, with an average of 73 Canadians diagnosed daily. 2  Merck known as MSD outside the United States … Approval Based on Significant Progression Free Survival Findings from Pha...

Merck Canada and MaRS Team Up to Launch Lung Cancer Innovation Challenge Challenge aimed at improving patient outcomes by identifying solutions to reduce time between diagnosis and treatment for lung cancer patients Merck Canada and MaRS Discovery District are proud to launch the Lung Cancer Innovation Challenge . The competition challenges Ontario -based innovators to identify, implement and scale solutions that can enhance an Ontario lung cancer patient’s journey by seeking to reduce … C...